Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.
Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.
MedTrials.co.uk is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.
Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.
If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.
Clinical research companies often offer financial compensation for your time and expenses.
NeuroEM Therapeutics, Inc., a Phoenix-based medical device R&D company, has announced that it has begun a study with a premiere research university to test its Transcranial Electromagnetic… Go to Source
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and… Go to Source
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time at the ESMO 2014 Congress in… Go to Source
The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. Go to Source
ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, has announced positive top-line results from HARMONIZE (ZS004), its… Go to Source
Traslational Cancer Drugs Pharma, S.L. has announced in BioSpain that their Phase I study performed in patients with advanced solid tumors with TCD-717 has been successfully completed. Go to Source